Get the Stockscreener App
0.1904
4.85%
-0.0096
Aspire Biopharma Holdings Inc stock is traded at $0.1904, with a volume of 2.37M.
It is down -4.85% in the last 24 hours and down -83.16% over the past month.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
See More
Previous Close:
$0.20
Open:
$0.19
24h Volume:
2.37M
Relative Volume:
0.25
Market Cap:
$956.09K
Revenue:
$6,200
Net Income/Loss:
$-24.48M
P/E Ratio:
-0.0392
EPS:
-4.8539
Net Cash Flow:
$-4.92M
1W Performance:
-22.01%
1M Performance:
-83.16%
6M Performance:
-98.20%
1Y Performance:
-98.71%
1-Day Range:
$0.1817
$0.192
1-Week Range:
$0.1817
$0.2348
52-Week Range:
$0.1643
$35.01
Aspire Biopharma Holdings Inc Stock (ASBP) Company Profile
Name
Aspire Biopharma Holdings Inc
Sector
Industry
Phone
561-704-8527
Address
23150 FASHION DRIVE, SUITE 232, ESTERO
Compare ASBP vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASBP
Aspire Biopharma Holdings Inc
|
0.1903 | 1.00M | 6,200 | -24.48M | -4.92M | -4.8539 |
VRTX
Vertex Pharmaceuticals Inc
|
429.46 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.42 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.49 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
305.42 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
310.03 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Aspire Biopharma Holdings Inc Stock (ASBP) Latest News
ASBP Stock Jumps 21% On Buyback Offer – Retail Believes Every Dip’s A Buying Opportunity - MSN
Why Qualcomm Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Sahm
ASBP Stock Price, Quote & Chart | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
Aspire Biopharma's BUZZ BOMB(TM) Disrupts Energy Category with New Convenience Store Pack - Stevens Point Journal
ASBP: A Platform Approach to Drug Delivery with an Unconventional Path to Commercialization - Zacks Small Cap Research
ASBP - Finviz
LCID, ASBP, WLDS stocks hit 52-week lows: What drove the selloff? - MSN
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
ASBP bulls back in control after 78% crash: What changed? - MSN
Aspire Biopharma announces $5M share repurchase program - MSN
Aspire Biopharma regains Nasdaq minimum bid price compliance - MSN
Aspire Biopharma (ASBP) asks holders to approve warrants, $0.00001 exercise price - Stock Titan
Aspire Biopharma authorizes $5 million stock buyback program By Investing.com - Investing.com South Africa
Aspire Biopharma authorizes $5 million stock buyback program - Investing.com UK
Aspire Biopharma Announces $5.0 Million Share Repurchase Program - ACCESS Newswire
No expiration date: Aspire can spend up to $5M buying back shares - Stock Titan
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, Partners with Blue Shark Beverages to Expand Southern California Distribution - Bluffton Today
Aspire Biopharma secures up to $21M in convertible preferred stock financing - MSN
Aspire Biopharma's Wholly Owned Subsidiary, Buzz Bomb Caffeine Company, to Showcase BUZZ BOMB(TM) Caffeine and its Innovative Sublingual Delivery Technology at The Sports & Active Nutrition Summit - Bluffton Today
Aspire Biopharma names new executive chair - MSN
Aspire Biopharma Announces Closing of Second and Final Tranche of $21 Million Private Placement by Select Investors; Secures Commitment Letter for $22.5M Credit Facility to Fund the DCS Acquisition - Corsicana Daily Sun
ASBP Technical Analysis | Trend, Signals & Chart Patterns | ASPIRE BIOPHARMA HOLDINGS IN (NASDAQ:ASBP) - ChartMill
ASBPW (Aspire Bio) leadership prioritizes late-stage clinical trial advancement to drive long-term shareholder value.Verified Stock Signals - Cổng thông tin điện tử tỉnh Tây Ninh
Aspire Bio (ASBP) Stock Employment Data (+8.28%) 2026-04-22Shared Trade Alerts - Xã Thanh Hà
ASBP Financials: Income Statement, Balance Sheet & Cash Flow | Aspire Biopharma Holdings Inc - Stock Titan
ASBP Stock Back On Retail Radar After 78% Crash – Bulls Eye $1 Comeback - Stocktwits
Why Amazon Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket - Sahm
LCID, ASBP, WLDS Stocks Hit 52-Week Lows: What Drove The Selloff? - Stocktwits
Aspire Biopharma Holdings Inc Stock (ASBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.78%
3.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):